Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Mayo Clinic study finds sparing the hippocampus leads to better outcomes.
Experts say the findings do not have clear implications for humans.
Studies have “given us the confidence” that the current safety limits remain acceptable.
Mutation revelation is a boon in an era of targeted therapies, say oncologists at UCSF, Children’s National Health System.
Financial toxicity is also about the systemic designs of our assistance programs, which are not equipped to meet the needs of the very ill.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.
We are a community; how might we all learn together from our shared yet unique experiences?
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
Opdivo plus Yervoy delays disease progression in people with melanoma brain metastases.
The Republican lawmaker was diagnosed with glioblastoma, an aggressive brain cancer, last year.
In our brain-tumor community, each of us spend countless hours wondering what we will do when we receive news of a “bad scan.”
David Reardon, MD, and Patrick Y. Wen, MD, of Dana-Farber Cancer Institute talk targeted therapies and immunotherapy.
Fred Hutchinson scientist to use nanoparticles to reprogram macrophages to tackle brain tumors.
After living with this disease for two years, I extend my deepest gratitude to those who follow my journey. We mark this milestone together.
The potential new treatment would use patients’ own immune cells to target tumors.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.